PDI extends sales service agreement with top-10 pharma company

Share this article:

PDI, Inc. announced that it has extended its sales services agreement with a top-10 pharma company through April 2009 to promote its anti-viral medication on a seasonal basis. This initiative is expected to generate approximately $10.5M during the 2007-2008 season, PDI said.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions